Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24658827 | 0.79 | MAOA (0.35) | ATMEPHX1 | |
| SCHEMBL24658468 | 0.78 | KMT2A (0.51) | ALDH1A1ATMKDM4E | |
| SCHEMBL24658658 | 0.78 | HPGD (0.34) | ALDH1A1ATMNPSR1SMN1; SMN2EPHX1 | |
| SCHEMBL12513739 | 0.72 | KMT2A (0.40) | ALDH1A1NPSR1SMN1; SMN2EPHX1 | |
| SCHEMBL12436696 | 0.72 | KMT2A (0.40) | ALDH1A1NPSR1SMN1; SMN2EPHX1 | |
| SCHEMBL24658764 | 0.72 | CYP3A4 (0.32) | NPSR1SMN1; SMN2EPHX1 | |
| SCHEMBL2093857 | 0.71 | — | — | |
| SCHEMBL12510421 | 0.69 | SELL (0.37) | ALDH1A1KDM4ENPSR1SMN1; SMN2EPHX1 | |
| SCHEMBL13450328 | 0.68 | EPHX2 (0.45) | ALDH1A1NPSR1SMN1; SMN2EPHX1 | |
| SCHEMBL1715478 | 0.67 | SMN1; SMN2 (0.64) | ALDH1A1KDM4ENPSR1SMN1; SMN2EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022173756-A1 | ANTIBACTERIAL COMPOUNDS | FORGE THERAPEUTICS, INC. (US) | 2022-08-18 | — | — | WO | disclosed |